GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
The clinical-stage psychedelics biotech GH Research PLC (NASDAQ: GHRS) reported its financial results for Q3 2023 ended September 30, showing:
Pot Products Drive Profit For This Vape-Tech Company: Q3 Revenue Spikes YoY, Loss Narrows
Ispire Technology Inc. (NASDAQ: ISPR) reported its first quarter financial results on Tuesday, revealing a 59.1% year-over-year increase in revenue to $42.9 million in the three months ended Sept. 30, 2023.
Hemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%
CV Sciences, Inc. (OTCQB: CVSI), a consumer wellness company specializing in hemp extracts and other science-backed, natural ingredients and products, announced its financial results for the quarter ended September 30, 2023.
Enveric Biosciences’ Revenue Drops In Q3 2023 As Next-Gen Psychedelics Advance To Clinical Trials
Enveric Biosciences (NASDAQ: ENVB), a biopharma company developing novel neuroplastogenic small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, reported its financials for Q3 2023 ended September 30, 2023, showing:
Cannabist Holdings’ Revenue Dips But Holds Steady At $129M In Q3, Announces Stock Buyback
Cannabist Company reports Q3 revenue of $129M and announces stock buyback plan, showcasing strategic financial moves and growth.
IM Cannabis’ Q3 Earnings: Unpacking Revenue And Profit Shifts
Explore IM Cannabis Corp's Q3 2023 financial results, revealing a decrease in revenue but an increase in gross profit amid market challenges.
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of around C$1 million sequentially but an increase of C$1.3 million over the year.
Atai Life Sciences’ Q3 Earnings: Near $20M Burned QoQ, Says Funding ‘Sufficient’ To Streamline 2026
Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023.
In numbers:
Cannabis REIT Stock Trading Higher On Reporting 17% YoY Revenue Growth In Q3
Zoned Properties, Inc. (OTCQB: ZDPY), a cannabis-focused real estate development firm reported its third quarter financial results on Tuesday for the three and nine-month period ended Sept. 30, 2023.
Mike Tyson & Ric Flair Team Up With Clipper For Limited-Edition Lighters
Hemp wrap brand P&L Sales Group and popular reusable lighter brand Clipper Lighter are collaborating on an exclusive collection with Mike Tyson and Ric Flair, nostalgic icons, now influential in the smoking space.